March 2026
1. TRUJILLO A, Munguia N, Craig N, Wilkes R, et al
   Genome-wide Study Identifies a Locus Associated with Atopic Dermatitis Severity in a Canine Model.
   J Invest Dermatol. 2026 Mar 25:S0022-202X(26)01000.
   

   >> Share

   
   
2. JIANG W, Xie X, Yang S, Xu R, et al
   Basophil Activity in Atopic Dermatitis: Distinct Immunomodulatory Roles of Dupilumab and Abrocitinib.
   J Invest Dermatol. 2026 Mar 9:S0022-202X(26)00746.
   

   >> Share

   
   
3. OTROFANOWEI E, Ahogo KC, Atadokpede F, Bahloul E, et al
   Accessibility And Affordability Of Emollients In The Management Of Atopic Dermatitis (AD) In Africa.
   J Invest Dermatol. 2026 Mar 2:S0022-202X(26)00137.
   

   >> Share

   
   February 2026
4. XIAO F, Wu R, Wu N, Xie Y, et al
   Fat mass and obesity-associated (FTO)/SOCS6-m(6)A axis epigenetic modification links obesity to atopic dermatitis by regulating keratinocyte function.
   J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00068.
   

   >> Share

   
   January 2026
5. DUBRAC S, Combarros D, Olah A, Cadiergues MC, et al
   Recommendations on in vitro models for canine atopic dermatitis.
   J Invest Dermatol. 2026 Jan 20:S0022-202X(25)03668.
   

   >> Share

   
   December 2025
6. KIM KC, Lee JH
   Harnessing cannabidiol: an approach to attenuating Th2 inflammation via JAK/STAT signaling and modulating CB2 receptor in atopic dermatitis.
   J Invest Dermatol. 2025 Dec 15:S0022-202X(25)03640.
   

   >> Share

   
   November 2025
7. BISSONNETTE R, Saint-Cyr Proulx E, Correa da Rosa J, Estrada Y, et al
   Ruxolitinib Cream Demonstrated Rapid Reductions in Itch and Atopic Dermatitis Signs That Correlated With Biomarkers.
   J Invest Dermatol. 2025 Nov 18:S0022-202X(25)03550.
   

   >> Share

   
   
8. KAWAKAMI E
   Dynamic Network Biomarker Analysis Reveals Predisease State in Atopic Dermatitis.
   J Invest Dermatol. 2025 Nov 11:S0022-202X(25)03458.
   

   >> Share

   
   
9. PARK JJ, Richards D, Tseng PH, Ebata T, et al
   Methods to Validate Digital Health Technologies for Dermatology.
   J Invest Dermatol. 2025;145:2668-2675.
   

   >> Share

   
   October 2025
10. MISERY L, Talagas M, Le Gall-Ianotto C
    Dupilumab's Effects on Itch Sensitization in Atopic Dermatitis.
    J Invest Dermatol. 2025 Oct 21:S0022-202X(25)02477.
    

    >> Share

    
    September 2025
11. SENSUI T, Iwasaki K, Aihara K
    Identification of Pre-Disease State in NC/Nga Mice with Atopic Dermatitis-Like Symptoms Using Dynamical Network Biomarkers.
    J Invest Dermatol. 2025 Sep 22:S0022-202X(25)02436.
    

    >> Share

    
    
12. SCHNEIDERMAN M
    Association of Adult Atopic Dermatitis and Repetitive Strain Injury: A U.S. Population-Based Study.
    J Invest Dermatol. 2025 Sep 19:S0022-202X(25)02435.
    

    >> Share

    
    
13. BASH GN, Baghoomian W, Seshadri R, Latour E, et al
    Aberrant Epidermal Innervation in Adults with Atopic Dermatitis is Restored Following Dupilumab Treatment.
    J Invest Dermatol. 2025 Sep 10:S0022-202X(25)02424.
    

    >> Share

    
    
14. GALLO RL
    Drugs and Bugs in Atopic Dermatitis: Benefits to the Skin Microbiome from Targeted Immunotherapies.
    J Invest Dermatol. 2025 Sep 10:S0022-202X(25)02325.
    

    >> Share

    
    
15. BURSHTEIN J, Bunick CG, Vleugels RA, Armstrong AW, et al
    Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy.
    J Invest Dermatol. 2025 Sep 6:S0022-202X(25)02338.
    

    >> Share

    
    
16. KROGH NS, Prieto-Merino D, Coker B, Birkner T, et al
    Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries Collaboration.
    J Invest Dermatol. 2025 Sep 3:S0022-202X(25)02407.
    

    >> Share

    
    
17. WANG Q, Qiu Q, Sun H, Liu Y, et al
    Distinct Comorbidity Clusters and Their Genetic Associations with Atopic Dermatitis in Middle-Aged and Elderly Adults.
    J Invest Dermatol. 2025 Sep 2:S0022-202X(25)02404.
    

    >> Share

    
    August 2025
18. WIEGMANN H, Witte F, Renkhold L, Westmeier J, et al
    Cutaneous neuroanatomical and cellular response to dupilumab treatment in atopic dermatitis.
    J Invest Dermatol. 2025 Aug 22:S0022-202X(25)02353.
    

    >> Share

    
    
19. BECKER SL, Bash GN, Begolka WS, Wallace-Hood T, et al
    Improving the quality of atopic dermatitis epidemiological research in the United States- A systematic review of disease definitions and related content in national surveys.
    J Invest Dermatol. 2025 Aug 13:S0022-202X(25)02337.
    

    >> Share

    
    
20. BUNICK CG
    Biologic Therapies Targeting Type 2 Signaling in Atopic Dermatitis: A Comparative Review of Structural and Thermodynamic Differences in Mechanism of Action.
    J Invest Dermatol. 2025 Aug 5:S0022-202X(25)02203.
    

    >> Share

    
    
21. SHOBNAM N, Ratley G, Saksena S, Yadav M, et al
    Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD.
    J Invest Dermatol. 2025;145:1953-1968.
    

    >> Share

    
    July 2025
22. THOMOVA T, Jedlickova H, Bohm J, Holochova P, et al
    EFFECT OF SYSTEMIC THERAPIES ON SKIN BACTERIOME IN PATIENTS WITH ATOPIC DERMATITIS: A PILOT PROSPECTIVE STUDY.
    J Invest Dermatol. 2025 Jul 28:S0022-202X(25)02307.
    

    >> Share

    
    
23. BAZZINI C, Bertschi NL, Steck O, Luther F, et al
    Human T Helper 9 Cells Rely on Peroxisome Proliferator-Activated Receptor-gamma-Mediated Cystine Uptake to Prevent Lipid Peroxidation and Bioenergetic Failure.
    J Invest Dermatol. 2025;145:1693-1705.
    

    >> Share

    
    June 2025
24. BUNICK CG, Armstrong AW, Grada A, Soliman AM, et al
    The Epidemiology of Atopic Dermatitis Among Adults and Adolescents with Alopecia Areata in the United States.
    J Invest Dermatol. 2025 Jun 26:S0022-202X(25)02236.
    

    >> Share

    
    
25. GELLER S
    Cutaneous T-Cell Lymphoma after Dupilumab Treatment in Patients with Atopic Dermatitis: A Response Letter to James et al.
    J Invest Dermatol. 2025 Jun 24:S0022-202X(25)00542.
    

    >> Share

    
    
26. WANG J, Ho M, Bunick CG
    Chemical, Biochemical, and Structural Similarities and Differences of Dermatological cAMP Phosphodiesterase-IV Inhibitors.
    J Invest Dermatol. 2025;145:1471-1488.
    

    >> Share

    
    May 2025
27. OCHIAI S, Larson AR, Mayer JU, Yang J, et al
    Allergic Skin Inflammation Drives IL-4-Dependent Differentiation of Dermal CD11b-low Dendritic Cells.
    J Invest Dermatol. 2025 May 28:S0022-202X(25)00536.
    

    >> Share

    
    
28. FUNCH AB, Weber JF, Mraz V, Kongsbak-Wismann M, et al
    CD8(+) Skin-Resident Memory T Cells Require TCR Signaling for their Persistence in a Mouse Model of Allergic Contact Dermatitis.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00529.
    

    >> Share

    
    
29. ZHANG J, Yu Y, Zhao P, Yuan L, et al
    Clinical characteristics of hand eczema and its association with atopic dermatitis in the Chinese population: A multicenter cross-sectional study.
    J Invest Dermatol. 2025 May 19:S0022-202X(25)00486.
    

    >> Share

    
    
30. LEE M, Mikol V, Truong V, Attieh E, et al
    Atuzabrutinib Topical Gel Does Not Improve Disease Activity in Patients with Mild-to-Moderate Atopic Dermatitis: Findings from a Phase 2a Trial.
    J Invest Dermatol. 2025 May 5:S0022-202X(25)00462.
    

    >> Share

    
    
31. FAHMY LM, Adeuyan OO, de Jong A
    CD1a and Lipids as Mediators of T Cell Activation in the Skin.
    J Invest Dermatol. 2025 May 3:S0022-202X(25)00383.
    

    >> Share

    
    April 2025
32. STAMATAS GN, Insel R, Sorensen N, Palleja A, et al
    Shifts in Infant Skin Microbiome at 2 Months following Short-term Emollient Use from Birth are Associated with Reduced Prevalence of Atopic Dermatitis at 12 Months in a High-Risk Cohort.
    J Invest Dermatol. 2025 Apr 7:S0022-202X(25)00380.
    

    >> Share

    
    March 2025
33. ZHANG H, Tang S, Chen X, Wang M, et al
    Association Between Emotional Distress and Atopic Dermatitis: A Cross-Sectional Study.
    J Invest Dermatol. 2025 Mar 24:S0022-202X(25)00365.
    

    >> Share

    
    
34. LEBTIG M, Peschel A, Kretschmer D
    Role of Formyl Peptide Receptor 2 and Toll-Like Receptor 2 in Skin Barrier Function and Atopic Dermatitis.
    J Invest Dermatol. 2025 Mar 9:S0022-202X(25)00100.
    

    >> Share

    
    
35. WANG Y, Yin H, Li Z, Wu H, et al
    Blood transcriptome signature as indicator and predictor for efficacy of abrocitinib in treatment of atopic dermatitis.
    J Invest Dermatol. 2025 Mar 7:S0022-202X(25)00311.
    

    >> Share

    
    February 2025
36. INGEN-HOUSZ-ORO S, Matei I, Gaillet A, Gueudry J, et al
    Diagnosing and Managing Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017-2023.
    J Invest Dermatol. 2025 Feb 27:S0022-202X(25)00078.
    

    >> Share

    
    
37. KAMP E, Ascott A, George SMC
    Eczema Severity Scoring in Skin of Color: A Review of Current Best Practice and Need for Future Improvement.
    J Invest Dermatol. 2025 Feb 24:S0022-202X(25)00099.
    

    >> Share

    
    January 2025
38. HU J, Zhao Q, Che D, Peng B, et al
    Epidermal Mechanical Scratching-Induced ROS Exacerbates the Itch-Scratch Cycle via TRPA1 Activation on Mast Cells in Atopic Dermatitis.
    J Invest Dermatol. 2025 Jan 30:S0022-202X(25)00076.
    

    >> Share

    
    
39. ABUABARA K, Kidd SA, Ye M, Tully J, et al
    The impact of childhood stressful life events on atopic dermatitis disease activity and severity.
    J Invest Dermatol. 2025 Jan 28:S0022-202X(25)00081.
    

    >> Share

    
    
40. GOHARA Y, Kinoshita R, Tomonobu N, Jiang F, et al
    An S100A8/A9 neutralizing antibody potently ameliorates contact hypersensitivity and atopic dermatitis symptoms.
    J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00029.
    

    >> Share

    
    
41. BRIOT J, Pons C, Foucher A, Goudouneche D, et al
    Prolyl Endopeptidase Is Involved in Filaggrinolysis and Cornification.
    J Invest Dermatol. 2025;145:98-108.
    

    >> Share

    
    December 2024
42. AZEEM M, Helal M, Klein-Hessling S, Serfling E, et al
    NFATc1 fosters allergic contact dermatitis responses by enhancing the induction of IL-17-producing CD8 cells.
    J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03036.
    

    >> Share

    
    
43. TANDON R, Harder I, Stolzl D, Hubenthal M, et al
    Tralokinumab Treatment of Atopic Dermatits Induces A Progressive Transcriptomic Response.
    J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03035.
    

    >> Share

    
    
44. ISKANDAR RJ, Drucker AM
    A Framework to Efficiently Monitor the Comparative Safety of Systemic Immunomodulatory Medications for Atopic Dermatitis.
    J Invest Dermatol. 2024 Dec 20:S0022-202X(24)02961.
    

    >> Share

    
    
45. BRAHIMI N, Croitoru D, Saidoune F, Zabihi H, et al
    From Viral Infection to Skin Affliction: Unveiling Mechanisms of Cutaneous Manifestations in COVID-19 and Post-COVID Conditions.
    J Invest Dermatol. 2024 Dec 10:S0022-202X(24)01883.
    

    >> Share

    
    November 2024
46. YEW YW, Loh M, Brown SJ
    Understanding Atopic Dermatitis in Asian and European Population Cohorts Using Complementary Omics Techniques.
    J Invest Dermatol. 2024 Nov 5:S0022-202X(24)02171.
    

    >> Share

    
    
47. MASISON J, Lehmann HP, Wan J
    Utilization of Computable Phenotypes in Electronic Health Record Research: A Review and Case Study in Atopic Dermatitis.
    J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02103.
    

    >> Share

    
    October 2024
48. DAI X, Mizukami Y, Watanabe K, Tsuda T, et al
    Trehalose prevents IL-4/IL-13-induced skin barrier impairment by suppressing IL-33 expression and increasing Nrf2 activation in human keratinocytes in vitro.
    J Invest Dermatol. 2024 Oct 7:S0022-202X(24)02175.
    

    >> Share

    
    
49. SCHNEEWEISS MC, Glynn RJ, Wyss R, Anand P, et al
    A scalable approach to assess the safety of recently marketed systemic treatments for atopic dermatitis in clinical practice.
    J Invest Dermatol. 2024 Oct 1:S0022-202X(24)02169.
    

    >> Share

    
    September 2024
50. FRISOLI ML, Ko WC, Martinez N, Afshari K, et al
    Single cell RNA-sequencing reveals molecular signatures that distinguish allergic from irritant contact dermatitis.
    J Invest Dermatol. 2024 Sep 26:S0022-202X(24)02152.
    

    >> Share

    
    
51. CASSAGNE M, Galiacy S, Kychygina A, Chapotot E, et al
    Superficial Conjunctival Cells from Dupilumab-treated Atopic Dermatitis Patients with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature.
    J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02102.
    

    >> Share

    
    August 2024
52. LI Y, Chen W, Zhu X, Mei H, et al
    Neuronal BST2: A Pruritic Mediator alongside Protease-Activated Receptor 2 in the IL-27-Driven Itch Pathway.
    J Invest Dermatol. 2024;144:1829-1842.
    

    >> Share

    
    June 2024
53. HUANG KR, Mai-Yi Fan S, Tai KY, Lin JD, et al
    Essential role of macrophages in contact hypersensitivity-induced hair regeneration.
    J Invest Dermatol. 2024 Jun 25:S0022-202X(24)01739.
    

    >> Share

    
    
54. SHIOHARA T, Mizukawa Y
    The Neglected Beneficial Role of Sweat in Atopic Dermatitis Is Spotlighted at Last.
    J Invest Dermatol. 2024 Jun 22:S0022-202X(24)00381.
    

    >> Share

    
    
55. MA X, Zhao H, Song JK, Zhang Z, et al
    Retracing from Outcomes to Causes: NRF2-Driven GSTA4 Transcriptional Regulation Controls Chronic Inflammation and Oxidative Stress in Atopic Dermatitis Recurrence.
    J Invest Dermatol. 2024 Jun 13:S0022-202X(24)01735.
    

    >> Share

    
    
56. SHEN S, Sobczyk MK, Paternoster L, Brown SJ, et al
    From GWASs toward Mechanistic Understanding with Case Studies in Dermatogenetics.
    J Invest Dermatol. 2024;144:1189-1199.
    

    >> Share

    
    May 2024
57. SONG Z, Gao M, Li T, Zhang Y, et al
    TRPV3-activated PARP1/AIFM1/MIF axis through oxidative stress contributes to atopic dermatitis.
    J Invest Dermatol. 2024 May 30:S0022-202X(24)00384.
    

    >> Share

    
    
58. BORZUTZKY A, Cabalin C
    From Thin to Thick: Weight Gain in Children Feeds the Risk of Atopic Dermatitis.
    J Invest Dermatol. 2024 May 14:S0022-202X(24)00281.
    

    >> Share

    
    
59. SCHMUTH M, Eckmann S, Moosbrugger-Martinz V, Ortner-Tobider D, et al
    Skin Barrier in Atopic Dermatitis.
    J Invest Dermatol. 2024;144:989-1000.
    

    >> Share

    
    
60. BROWN SJ, Gudjonsson JE
    Halting the Vicious Cycle of Atopic Dermatitis: Empowered by Scientific Understanding.
    J Invest Dermatol. 2024;144:917-918.
    

    >> Share

    
    April 2024
61. PASANEN A, Sliz E, Huilaja L, Reimann E, et al
    Identifying atopic dermatitis risk loci in 1,094,060 individuals with sub analysis of disease severity and onset.
    J Invest Dermatol. 2024 Apr 23:S0022-202X(24)00285.
    

    >> Share

    
    
62. VAN DEN BRINK NJM, Pardow F, Meesters LD, van Vlijmen-Willems I, et al
    Electrical Impedance Spectroscopy Quantifies Skin Barrier Function in Organotypic In Vitro Epidermis Models.
    J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00293.
    

    >> Share

    
    
63. PALLER AS, Scharschmidt TC, Kezic S, Irvine AD, et al
    Preclinical Atopic Dermatitis Skin in Infants: An Emerging Research Area.
    J Invest Dermatol. 2024 Apr 2:S0022-202X(24)00186.
    

    >> Share

    
    March 2024
64. ARADI P, Kovacs G, Kemecsei E, Molnar K, et al
    Lymphatics-dependent modulation of the sensitization and elicitation phases of contact hypersensitivity.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00261.
    

    >> Share

    
    
65. SAHEB KASHAF S, Kong HH
    Adding Fuel to the Fire? The Skin Microbiome in Atopic Dermatitis.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00082.
    

    >> Share

    
    
66. XIA E, Gaurav A, Noe MH, Mostaghimi A, et al
    Validation of the Diagnostic Code for Cutaneous Sarcoidosis in an Electronic Health Database: a Cross-sectional Analysis.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00212.
    

    >> Share

    
    
67. ISHIMARU H, Nakamoto K, Yamane M, Yamamoto T, et al
    Sweat Protects against Contact Hypersensitivity: Transient Sweat Suppression Compromises Skin Barrier Function in Mice.
    J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00196.
    

    >> Share

    
    
68. 
    WITHDRAWN: Expression of Concern: Zhou et al, Extracellular Vesicles of Commensal Skin Microbiota Alleviate Cutaneous Inflammation in Atopic Dermatitis Mouse Model by Re-Establishing Skin Homeostasis. J Invest Derm doi:10.1016/j.jid.2023.02.023.
    J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00173.
    

    >> Share

    
    
69. DROLL SH, Zhang BJ, Levine MC, Xue C, et al
    CASZ1 is Essential for Skin Epidermal Terminal Differentiation.
    J Invest Dermatol. 2024 Mar 6:S0022-202X(24)00172.
    

    >> Share

    
    
70. ROUSEL J, Mergen C, Schoones JW, Niemeyer-van der Kolk T, et al
    Similar alterations of the stratum corneum ceramide profile in atopic dermatitis, psoriasis and ichthyosis: results from a systematic review and meta-analysis.
    J Invest Dermatol. 2024 Mar 4:S0022-202X(24)00168.
    

    >> Share

    
    
71. DAS M, Mukherjee S, Geha RS
    Phosphodiesterase 4 Inhibitors, Basophils, and Atopic Dermatitis.
    J Invest Dermatol. 2024 Mar 3:S0022-202X(24)00096.
    

    >> Share

    
    
72. BRAHIMI N, Piguet V
    Autophagy during Severe Acute Respiratory Syndrome Coronavirus 2 Induced Leukocytoclastic Vasculitis: New Insights.
    J Invest Dermatol. 2024;144:441-443.
    

    >> Share

    
    
73. BETTUZZI T, Hoisnard L, Beytout Q, Ingen-Housz-Oro S, et al
    Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database.
    J Invest Dermatol. 2024;144:708-710.
    

    >> Share

    
    
74. WANG X, Mao D, Jia J, Zhang J, et al
    Benvitimod Inhibits IL-4- and IL-13-Induced Tight Junction Impairment by Activating AHR/ARNT Pathway and Inhibiting STAT6 Phosphorylation in Human Keratinocytes.
    J Invest Dermatol. 2024;144:509-519.
    

    >> Share

    
    February 2024
75. GALLO RL, Horswill AR
    Staphylococcus aureus: The Bug Behind the Itch in Atopic Dermatitis.
    J Invest Dermatol. 2024 Feb 29:S0022-202X(24)00002.
    

    >> Share

    
    
76. MUKHOPADHYAY S, Brown SJ
    FLG Knockdown-Related Skin-Lung Crosstalk Biologically Underpins an Filaggrin-Related Childhood Asthma Subtype.
    J Invest Dermatol. 2024 Feb 16:S0022-202X(24)00027.
    

    >> Share

    
    January 2024
77. YEO H, Ahn SS, Ou S, Yun SJ, et al
    The EGR1-ARTN axis in keratinocytes enhances the innervation of epidermal sensory neurons during skin inflammation induced by house dust mite extract from Dermatophagoides farinae.
    J Invest Dermatol. 2024 Jan 30:S0022-202X(24)00090.
    

    >> Share

    
    
78. BIER K, Senajova Z, Henrion F, Wang Y, et al
    Interleukin-26 potentiates type 2 skin inflammation in presence of interleukin-1beta.
    J Invest Dermatol. 2024 Jan 16:S0022-202X(24)00017.
    

    >> Share

    
    November 2023
79. ZHANG W, Akhtar N, Zhao J, Spandau DF, et al
    Fibronectin promotes wound healing in an atopic human skin xenografting model.
    J Invest Dermatol. 2023 Nov 30:S0022-202X(23)03118.
    

    >> Share

    
    
80. YU J, Song P, Bai Y, Dang E, et al
    CD36-SREBP1 Axis Mediates TSLP Production in Obesity-Exacerbated Atopic Dermatitis.
    J Invest Dermatol. 2023;143:2153-2162.
    

    >> Share

    
    
81. LIN FJ, Huang YH, Tsao CH, Hsieh WC, et al
    Galectin-12 Regulates Immune Responses in the Skin through Sebaceous Glands.
    J Invest Dermatol. 2023;143:2120-2131.
    

    >> Share

    
    October 2023
82. FUKUNAGA K, Tsukagoshi E, Kurata M, Mizukawa Y, et al
    Differential effects of HLA-B*15:11 and HLA-A*31:01 on carbamazepine-induced cutaneous adverse reactions.
    J Invest Dermatol. 2023 Oct 21:S0022-202X(23)02972.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share